Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Future Applications of the Selective Prostacyclin (IP) Receptor Agonist Selexipag in Pediatric Pulmonary Hypertension.

× No keyword cloud information.

7 in total

1. Transthoracic echocardiography for the evaluation of children and adolescents with suspected or confirmed pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and D6PK.

Authors: Martin Koestenberger; Christian Apitz; Hashim Abdul-Khaliq; Georg Hansmann
Journal: Heart Date: 2016-05 Impact factor: 5.994

2. Treatment of children with pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.

Authors: Georg Hansmann; Christian Apitz
Journal: Heart Date: 2016-05 Impact factor: 5.994

3. Single-Center Experience Using Selexipag in a Pediatric Population.

Authors: Roberto Gallotti; Diana E Drogalis-Kim; Gary Satou; Juan Alejos
Journal: Pediatr Cardiol Date: 2017-07-13 Impact factor: 1.655

4. Intravenous treprostinil infusion via a fully implantable pump for pulmonary arterial hypertension.

Authors: Ralf Ewert; Manuel J Richter; Regina Steringer-Mascherbauer; Ekkehard Grünig; Tobias J Lange; Christian F Opitz; Christian Warnke; Hossein-Ardeschir Ghofrani
Journal: Clin Res Cardiol Date: 2017-04-20 Impact factor: 5.460

5. The Need for Comprehensive Cardiac Catheterization in Children With Pulmonary Hypertension.

Authors: Georg Hansmann; Christian Apitz
Journal: J Am Coll Cardiol Date: 2016-03-01 Impact factor: 24.094

Review 6. Pulmonary Hypertension in Infants, Children, and Young Adults.

Authors: Georg Hansmann
Journal: J Am Coll Cardiol Date: 2017-05-23 Impact factor: 24.094

7. First-in-child use of the oral selective prostacyclin IP receptor agonist selexipag in pulmonary arterial hypertension.

Authors: Lianne M Geerdink; Harald Bertram; Georg Hansmann
Journal: Pulm Circ Date: 2017-05-12 Impact factor: 3.017

7 in total

1 in total

1. Should we use the oral selective IP receptor agonist selexipag off-label in children with pulmonary arterial hypertension?

Authors: Martin Koestenberger; Georg Hansmann
Journal: Pulm Circ Date: 2018 Jul-Sep Impact factor: 3.017

1 in total